Drug Profile
Monoclonal antibody - Genentech
Latest Information Update: 13 Jan 2022
Price :
$50
*
At a glance
- Originator Genentech
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Metabolic disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Metabolic-disorders in USA (Parenteral)
- 25 Oct 2011 Phase-I clinical trials in Metabolic disorders in USA (Parenteral)